Weiguang Medical focuses on independent R&D, global innovation and self-production of minimally invasive laser interventional diagnostic and therapeutic devices. The company has achieved autonomous control of detectors, acquisition cards and lasers. It says it fully masters three core underlying technologies: laser therapy, fiber‑optic catheters and image processing. Weiguang has built a hard‑tech, integrated diagnosis-and‑treatment platform covering multiple indications. Its product pipeline spans vascular intervention, urology and ophthalmology. The company recently received a strategic investment of over ¥100M to support its plans. Proceeds will fund continued new product development, clinical registration and overseas market expansion.

Total raised

$100M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2024